Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
L RamdinJ K Shute

Abstract

Increased expression of interleukin-8 (IL-8), a potent neutrophil chemoattractant, is associated with a number of inflammatory diseases. Interleukin-8 binds to the glycosaminoglycan (GAG) heparin and the protease inhibitor alpha2-macroglobulin, molecules which regulate the function of a number of cytokines. Heparan sulphate was previously shown to enhance neutrophil chemotactic responses to IL-8. The purpose of this study was to investigate the effect of heparin, heparan sulphate and alpha2-macroglobulin on IL-8 binding to neutrophils and subsequent functional effects in vitro. The binding of 125I-IL-8 to normal neutrophils at 4 degrees C was studied and the IL-8 induced neutrophil chemotactic response was investigated using micro-Boyden chambers. Complexation of IL-8 with alpha2-macroglobulin was confirmed using gel filtration chromatography. Heparin, but not heparan sulphate, inhibited the binding of 125I-IL-8 to neutrophils (IC50=26 microg/mL) and IL-8 induced neutrophil chemotactic responses (IC50=4 microg/mL). The specific inhibitory effect of heparin was apparently due to an interaction with IL-8 which was charge-dependent, since dextran sulphate had a greater inhibitory effect on chemotactic responses (IC50=2 microg/mL) ...Continue Reading

References

May 1, 1990·Immunology Today·K James
Dec 1, 1990·Immunology Today·C M Petersen, S K Moestrup
Oct 1, 1991·The Journal of Allergy and Clinical Immunology·D H BroideS I Wasserman
Jun 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A GórskiG Korczak-Kowalska
Mar 1, 1989·The American Review of Respiratory Disease·R BeasleyS T Holgate
Nov 1, 1987·Allergy·E C LasserR Stein
Aug 1, 1984·British Journal of Haematology·S P LevineL K Knieriem
Jul 1, 1995·The Journal of Allergy and Clinical Immunology·L GreiffM Andersson
Jun 1, 1995·Trends in Pharmacological Sciences·D J TyrellC P Page
Apr 21, 1995·Science·C A WatsonJ S Pober
Apr 1, 1995·The Journal of Allergy and Clinical Immunology·J V FahyH A Boushey
May 5, 1995·The Journal of Biological Chemistry·I U SchraufstätterC G Cochrane
Oct 1, 1994·American Journal of Respiratory and Critical Care Medicine·C WalkerB Villiger
May 1, 1994·Current Biology : CB·D P Witt, A D Lander
Jun 1, 1993·The American Review of Respiratory Disease·C P Page
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L M WebbA Rot
Jan 1, 1993·The American Review of Respiratory Disease·S D BowlerP S Lavercombe
Jun 1, 1993·The Journal of Allergy and Clinical Immunology·R A WarringaL Koenderman
Feb 1, 1996·International Archives of Allergy and Immunology·R E NockerT A Out
Apr 1, 1996·Clinical and Experimental Immunology·P CockwellC O Savage
Mar 1, 1996·Journal of Leukocyte Biology·K KurashimaK Matsushima
May 1, 1996·American Journal of Respiratory and Critical Care Medicine·J GarrigoT Ahmed
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·Z DiamantP J Sterk
Sep 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M SalmivirtaU Lindahl

❮ Previous
Next ❯

Citations

Aug 13, 2009·Nephron. Clinical Practice·Orfeas LiangosBertrand L Jaber
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·B Perks, J K Shute
Jan 10, 2002·American Journal of Respiratory and Critical Care Medicine·Ryoichi Suzuki, Arthur N Freed
Nov 5, 2003·American Journal of Respiratory and Critical Care Medicine·Lindsay J MarshallJanis K Shute
Jan 5, 2002·Expert Opinion on Investigational Drugs·S V Kane
Jan 7, 2014·Expert Opinion on Investigational Drugs·Madhur D ShastriRahul P Patel
Jun 19, 2003·British Journal of Pharmacology·Rachel A BrownClive P Page
Feb 9, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·J M CourtneyJ S Elborn
Mar 27, 2012·Carbohydrate Research·Denise SchlorkeAnnelie Pichert
Apr 19, 2017·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Ayca Yildiz-Pekoz, Yildiz Ozsoy
Apr 4, 2002·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T T HanselP J Barnes
May 8, 2001·European Journal of Gastroenterology & Hepatology·N P MichellM J Langman
Jun 23, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Domenico PaparellaEdward Young
Jun 10, 2000·Current Opinion in Nephrology and Hypertension·B H Rovin
Jul 15, 2017·Scientific Reports·Srinivas JayanthiDavid A Zaharoff
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L J MarshallJ K Shute
Aug 7, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lindsay J MarshallJanis K Shute
Apr 21, 2017·Science Translational Medicine·Nadine LohmannUwe Freudenberg
Apr 17, 2020·Frontiers in Immunology·Helena CrijnsPaul Proost
Sep 11, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Victoria J Broughton-HeadJanis K Shute

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.